B2M and cancer: For example, beta-2-microglobulin (B2M) mutations were all clonal (n = 4; Fig. 4b and Extended Data Fig. 1), and matched RNA-seq revealed significantly decreased B2M expression in these cancers, confirming the impact of these mutations (Extended Data Fig. 6a).